Date
- 2024 (29)
- 2023 (48)
- 2022 (26)
- 2021 (102)
- 2020 (61)
- 2019 (127)
- 2018 (41)
- 2017 (23)
- 2016 (26)
- 2015 (14)
- 2014 (22)
- 2013 (8)
- 2012 (3)
- 2010 (2)
- 2009 (12)
- 2008 (6)
- 2007 (12)
- 2006 (12)
- 2005 (15)
- 2004 (5)
- 2003 (3)
- 2002 (7)
- 2001 (4)
- 2000 (12)
- 1999 (5)
- 1998 (4)
- 1997 (1)
- 1996 (10)
- 1995 (2)
- 1994 (6)
- 1993 (6)
- 1991 (23)
Results for
"[search-keyword]"
Sponsor content
677 result(s) found, displaying 141 to 150
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Influenza Haemagglutinin Recombinant
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: dupilumab.
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALPROLIX eftrenonacog alfa (rhu) 4000 IU powder for injection vial and diluent pre-filled syringe.
-
Designation or determinationProvisional approval
-
Cancellation by sponsorRequested by Sanofi-Aventis Australia Pty Ltd